That is different from claiming that a microdose has special brain-protective effects
3A, B, S4A, B, and Supplementary Data S3)
Treatment is supervised by board-certified physicians, and every patient receives a medical evaluation before prescription
In the meta-analysis of 3 studies 20,28,32 which compared a GLP-1-based therapy against a comparator, GLP-1-based therapies were found to increase % FMD non-significantly (mean difference [95% CI] in the changes from baseline: 1.65 [0.89, 4.18] %
There remains a lot to learn and know about these drugs, so it is a concern of employers, not just financial, but the health and well-being of their covered members.
Wang et al., 2022)